Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $2.08B | 3.93% |
10,104,300
-1,187,500
| -11% | -$250M |
|
|
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $841M | 1.59% |
4,087,200
+4,085,200
| +204,260% | +$859M |
|
|
NBL
3
DELISTED
Noble Energy, Inc.
NBL
| $372M | 0.7% |
8,725,285
+1,053,023
| +14% | +$49.7M |
|
4
NextEra Energy
NEE
$174B
| $372M | 0.7% |
15,171,008
-2,345,172
| -13% | -$59.6M |
|
|
5
Biogen
BIIB
$32B
| $372M | 0.7% |
920,090
+440,068
| +92% | +$177M |
|
6
American Electric Power
AEP
$65.8B
| $357M | 0.68% |
6,744,107
-789,217
| -10% | -$43.7M |
|
7
Sempra
SRE
$54.2B
| $345M | 0.65% |
6,964,456
+1,327,764
| +24% | +$70.3M |
|
8
Meta Platforms (Facebook)
META
$1.4T
| $325M | 0.61% |
3,790,441
+361,846
| +11% | +$29.5M |
|
|
PPL
9
PPL Corp
PPL
$25.9B
| $321M | 0.61% |
10,887,864
+9,734,698
| +844% | +$304M |
|
10
Ameren
AEE
$29.4B
| $264M | 0.5% |
7,001,361
+133,720
| +2% | +$5.37M |
|
11
Occidental Petroleum
OXY
$61.3B
| $263M | 0.5% |
3,388,636
+1,854,430
| +121% | +$145M |
|
12
McDonald's
MCD
$192B
| $261M | 0.49% |
2,744,239
+690,916
| +34% | +$66.8M |
|
13
DTE Energy
DTE
$28.1B
| $260M | 0.49% |
4,090,868
+706,520
| +21% | +$47.3M |
|
14
EQT Corp
EQT
$33.6B
| $250M | 0.47% |
5,644,519
+2,577,359
| +84% | +$121M |
|
15
HF Sinclair
DINO
$17.3B
| $248M | 0.47% |
5,815,855
+482,182
| +9% | +$19.5M |
|
|
TWX
16
DELISTED
Time Warner Inc
TWX
| $247M | 0.47% |
2,822,710
+307,069
| +12% | +$26.2M |
|
17
Amazon
AMZN
$2.79T
| $241M | 0.46% |
11,083,120
+837,660
| +8% | +$17.5M |
|
18
Exelon
EXC
$45.1B
| $237M | 0.45% |
10,595,968
+1,865,664
| +21% | +$44.7M |
|
|
EGN
19
DELISTED
Energen
EGN
| $234M | 0.44% |
3,429,045
+1,561,994
| +84% | +$109M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals
ALXN
| $234M | 0.44% |
1,291,973
+388,617
| +43% | +$67.1M |
|
|
DISH
21
DELISTED
DISH Network Corp.
DISH
| $233M | 0.44% |
3,438,891
+1,130,087
| +49% | +$79M |
|
22
Bausch Health
BHC
$2.41B
| $232M | 0.44% |
1,044,964
+131,754
| +14% | +$29.2M |
|
23
TechnipFMC
FTI
$30.4B
| $223M | 0.42% |
7,216,851
+2,928,640
| +68% | +$90.1M |
|
|
NFX
24
DELISTED
Newfield Exploration
NFX
| $221M | 0.42% |
6,112,710
-1,206,199
| -16% | -$44.9M |
|
25
NRG Energy
NRG
$23.8B
| $218M | 0.41% |
9,513,340
+2,698,886
| +40% | +$67.4M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.